healthcare

healthcare Articles

Biogen reported better than expected first-quarter financial results before the markets opened on Wednesday.
BioNTech shares shot up on Wednesday after the company announced, in conjunction with Pfizer, that its COVID-19 vaccine program was approved in Germany.
Cyclacel Pharmaceuticals shares were crushed on Tuesday after the company announced the pricing of a secondary offering.
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
While markets have been recovering since mid-March, cannabis stocks as a whole have not kept pace. Tilray shares have performed the best in this time, more than doubling off of their all-time lows.
Edison Nation shares more than doubled on Thursday after the company announced that it has received over $10 million in orders for the purchase of personal protective equipment.
Atossa Therapeutics is the newest company to join the fight against COVID-19, and its shares surged early on Thursday.
Applied DNA Sciences is the newest company to see a big boost riding the coronavirus wave. In a sense, the company is getting into the vaccine business.
UnitedHealth Group released bettern than expected first-quarter financial results before the markets opened on Wednesday.
UnitedHealth is set to report its most recent quarterly results before the markets open on Wednesday.
Fatal cases of COVID-19 hit a number on Tuesday that is larger than the number of gun suicides in all of last year.
Aikido Pharma is not necessarily a household name, but it may become one after the company secured a worldwide license agreement regarding a coronavirus treatment.
Johnson & Johnson released better than expected quarterly results and hiked its dividend before the markets opened on Tuesday.
Johnson & Johnson is scheduled to release its fiscal first-quarter financial results before the markets open on Tuesday.
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.